BUZZ-U.S. Stocks on the Move-Ebola drug developers, Westport, Mechel
(For faster updates on individual market-movers, Eikon users please use search string "STXBZ US"; for more market insights, including options activity, ; for the Day Ahead newsletter, link.reuters.com/mex49s; for the Morning News Call newsletter, link.reuters.com/nex49s) U.S. stock index futures pointed to a lower open on Wednesday, as caution arose following the first diagnosis of a patient in the United States with Ebola. Dow Jones industrial average futures were down 0.17 percent at 16,937, S&P 500 futures were down 0.24 percent at 1,960.75 and Nasdaq 100 futures were down 0.33 percent at 4,031.5.
** TEKMIRA PHARMACEUTICAL CORP, Tuesday close $21.14, +27.72 pct premarket
** BIOCRYST PHARMACEUTICALS INC, Tuesday close $9.78, +6.34 pct premarket
** SAREPTA THERAPEUTICS INC, Tuesday close $21.1, +4.98 pct premarket
** NEWLINK GENETICS CORP, Tuesday close $21.42, +10.08 pct premarket
** LAKELAND INDUSTRIES INC, Tuesday close $6.95, +12.95 pct premarket
Shares of several pharmaceutical companies with potential Ebola treatments jumped after the U.S. Centers for Disease Control and Prevention confirmed on Tuesday the first case of the virus diagnosed in the country.
Shares of Lakeland Industries, which makes protective clothing for healthcare and first responders, also jumped.